Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures
- PMID: 6590911
Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells growing in monolayer cultures
Abstract
The effects of butyrate, retinol, and retinoic acid were tested on growth and differentiation of human Y-79 retinoblastoma cells in monolayer cultures. Treatment with 4 mM butyrate resulted in marked growth inhibition of cells, due mostly to increased death rate. The effect was greater in serum-supported cultures in which the proliferation rate was high and the effect was less in the serum-free, defined medium in which the cells were differentiated and the growth rate was slow, suggesting a cell-cycle-specific action of this substance. Moreover, butyrate induced morphologic changes in the viable cells; these changes consisted of an elongated appearance of the cells and of retraction of long processes formed in the serum-free-supported cultures. Retinol at 20 microM also affected the cell viability both in serum-containing and in serum-free culture medium. Retinoic acid at 50 microM induced reversible growth inhibition of cells growing in serum-containing medium and cell death in the defined medium-supported cultures. Combination of 0.5 mM butyrate with 50 microM retinoic acid resulted in an enhanced inhibition of growth in an apparently synergistic fashion. These results demonstrated that butyrate, retinol, and retinoic acid suppressed Y-79 cell growth in vitro and could be useful in future studies of these compounds in retinoblastoma tumors in vivo.
Similar articles
-
Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.Invest Ophthalmol Vis Sci. 1991 May;32(6):1711-3. Invest Ophthalmol Vis Sci. 1991. PMID: 2032794
-
Distribution of the regulatory subunit of type II cAMP-dependent protein kinase in Y-79 retinoblastoma cells. Effect of butyrate.Invest Ophthalmol Vis Sci. 1986 Sep;27(9):1420-3. Invest Ophthalmol Vis Sci. 1986. PMID: 3528034
-
Control of retinoblastoma cell growth by differentiating agents: current work and future directions.Anticancer Res. 1986 May-Jun;6(3 Pt B):465-73. Anticancer Res. 1986. PMID: 2427007 Review.
-
Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.Cancer Res. 1982 Mar;42(3):1052-8. Cancer Res. 1982. PMID: 7059970
-
Retinoblastoma cells in tissue culture.Ophthalmic Paediatr Genet. 1988 Nov;9(3):171-99. doi: 10.3109/13816818809031495. Ophthalmic Paediatr Genet. 1988. PMID: 3068600 Review.
Cited by
-
Differentiation of human retinoblastoma in vitro into cell types with characteristics observed in embryonal or mature retina.Am J Pathol. 1986 Jun;123(3):542-52. Am J Pathol. 1986. PMID: 3013012 Free PMC article.
-
Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Mol Cell Biol. 1989 Oct;9(10):4337-44. doi: 10.1128/mcb.9.10.4337-4344.1989. Mol Cell Biol. 1989. PMID: 2573830 Free PMC article.
-
Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation.Environ Health Perspect. 1989 Mar;80:3-15. doi: 10.1289/ehp.89803. Environ Health Perspect. 1989. PMID: 2538324 Free PMC article. Review.
-
Differentiation in a human retinal precursor cell line: limitation to multipotency.In Vitro Cell Dev Biol Anim. 1999 Sep;35(8):435-40. doi: 10.1007/s11626-999-0049-x. In Vitro Cell Dev Biol Anim. 1999. PMID: 10501082 No abstract available.
-
Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice.Invest Ophthalmol Vis Sci. 2004 Mar;45(3):764-8. doi: 10.1167/iovs.03-1114. Invest Ophthalmol Vis Sci. 2004. PMID: 14985288 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical